South Australian Medicines Evaluation Panel (SAMEP)
The South Australian Medicines Evaluation Panel (SAMEP) was established in 2011 as an expert standing committee of the South Australian Medicines Advisory Committee (SAMAC) to ensure that all public hospitals provide a consistent approach to the management of High Cost Medicines. The main role of SAMEP is to review the use of High Cost Medicines, for a list of medicines being reviewed or previously reviewed, see the High Cost Medicine reviews page.
SAMEP were the winners of the 2014 SA Health Award "Excellence in Non-clinical Services"
The role of SAMEP includes:
Evaluating the safety, the clinical efficacy and cost-effectiveness of high cost medicines proposed for inclusion in the Statewide High Cost Medicines Formulary.
Initiating reviews to evaluate the safety and effectiveness of high cost medicines which are not registered for use within Australia for the purpose of providing guidance to local hospital drug committees with regards to consideration of individual patient use requests.
Making recommendations to SAMAC with regards to which high cost medicines should be made available in South Australian public hospitals and on the potential place in therapy of these medicines.
Facilitating the monitoring of high cost medicine use in South Australian public hospitals.
SAMEP meet every two months to review high cost medicine formulary applications. The next scheduled meetings for 2022 are:
Chaired by Dr Tilenka Thynne, SAMEP includes specialist clinicians, pharmacists, health economists, an ethicist and a consumer representative. Members include:
Dr Tilenka Thynne, Clinical Pharmacologist and Endocrinologist, Flinders Medical Centre
Dr Damian Clark, Paediatric Neurologist, Women's and Children's Hospital
Dr Chris Pearson, General Medicine, Women's and Children's Hospital
Dr Ganessan Kichenadasse, Consultant, Medical Oncology, Flinders Medical Centre
Dr Sudarsha Selva-Nayagam Director Medical Oncology, Royal Adelaide Hospital
Ass Prof Michael Ward, Professorial Lead: Pharmacy and Biosciences, Discipline Leader: Pharmacy Education, UniSA Clinical and Health Sciences
Ms Joy Gailer, Clinical Pharmacist, Drug and Therapeutics Information Service, Repatriation General Hospital
Ms Catherine Booth, Clinical Pharmacist, Women's and Children's Hospital
Dr Benjamin Reddi, Staff Specialist, Intensive Care Unit, Royal Adelaide Hospital
Ms Naomi Burgess Director, Medicines & Technology Programs, SA Health (ex officio)
Dr Pravin Hissaria, Clinical Immunologist and Immunopathologist, Royal Adelaide Hospital
Ms Camille Schubert, Health Economist, Adelaide Health technology Assessment, University of Adelaide
Dr David Ross, Department of Haematology and Bone Marrow Transplantation, The Royal Adelaide Hospital
Mr David Tamblyn, Evaluator, Adelaide Health Technology Assessment, University of Adelaide
Dr Paul Wabnitz, Consultant Physician & Specialist Clinical Pharmacologist, Integrated Care, CALHN
Prof Brett Bowden, Consumer Representative
Dr Agnes Vitry, Senior Pharmacist, Executive Officer, Medicines & Technology Programs, SA Health
All enquiries regarding the High Cost Medicines policy or SAMEP should be directed to SAMEP@sa.gov.au.
You can search through to find related information.
Use of the information and data contained within this site or these pages is at your sole risk.
If you rely on the information on this site you are responsible for ensuring by independent verification its accuracy, currency or completeness.
This site includes links to other websites operated by community, business and government.
These linked websites will have their own terms and conditions of use and you should familiarise yourself with these.
All linked websites are linked 'as is' and the Government of South Australia:
does not sponsor, endorse or necessarily approve of any material on websites linked from or to this Site;
does not make any warranties or representations regarding the quality, accuracy, merchantability or fitness for purpose of any material on websites linked from or to this Site;
does not make any warranties or representations that material on other websites to which this site is linked does not infringe the intellectual property rights of any person anywhere in the world; and
does not authorise the infringement of any intellectual property rights contained in material in other websites by linking this site to those other websites.
If you use automatic language translation services in connection with this site you do so at your own risk.
The information and data on this site is subject to change without notice. The Government of South Australia may revise this disclaimer at any time by updating this posting.
The Government of South Australia, its agents, instrumentalities, officers and employees:
make no representations, express or implied, as to the accuracy of the information and data contained on this site
make no representations, express or implied, as to the accuracy or usefulness of any translation of the information on this site or any linked website into another language
make no representations as to the availability of the site and the availability of websites linked from or to the site
accept no liability however arising for any loss resulting from the use of the site and any information and data or reliance placed on it (including translated information and data)
make no representations, either expressed or implied, as to the suitability of the said information and data for any particular purpose
accepts no liability for any interference with or damage to a user's computer, software or data occurring in connection with or relating to this Site or its use or any website linked to this site
do not represent or warrant that applications or payments initiated through this site will in fact be received or made to the intended recipient. Users are advised to confirm the application or payment by other means.